COR

COR

Cencora Inc.

Revenue grew 100% of years10Y
Hold

Cencora, Inc. sources and distributes pharmaceuticals, including generic and specialty drugs, over-the-counter products, and healthcare supplies. It serves hospitals, pharmacies, and healthcare providers in the U.S. and internationally.

⚕️ Healthcare NYSE Listed 1995 $ USD
$1,000 invested 10 years ago $5,166today

Score Overview

1 Year
Score
Net Growth68.89%
Net TrendGrew
Net Income Consistency
Rev Growth3.56%
Rev TrendGrew
Revenue Consistency
5 Years
Score8.0
Net Growth70.45%
Net Trend80%
Net Income Consistency
Rev Growth55.51%
Rev TrendEvery year
Revenue Consistency
10 Years
Score
Net Growth83.82%
Net Trend60%
Net Income Consistency
Rev Growth126.61%
Rev TrendEvery year
Revenue Consistency
20 Years
Score7.1
Net Growth461.20%
Net Trend60%
Net Income Consistency
Rev Growth443.72%
Rev Trend95%
Revenue Consistency
30 Years
Score
Net Growth73x
Net Trend70%
Net Income Consistency
Rev Growth59x
Rev Trend97%
Revenue Consistency
All Time
Score
Net Growth257x
Net Trend71%
Net Income Consistency
Rev Growth71x
Rev Trend97%
Revenue Consistency

Explore the 2021 public Archive ranking →

Cencora Inc. fundamental performance

Between 2020 and 2025, revenue grew from $ 189.89B to $ 321.33B and net income went from -$ 3.39B to $ 1.55B. Revenue increased in every one of those 5 years; net income in 4.

Across Cencora Inc.'s full reported history, from 1995 to 2025, revenue grew from $ 4.66B to $ 321.33B and net income grew from $ 10M to $ 1.55B. Revenue increased in 97% of the years measured; net income in 71%.

Cencora Inc. currently holds a 20-year HDB Score of 7.1 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-09-01
$ 330.97
1 Year2025-08-29
$ 289.4014.36%
5 Years2021-09-01
$ 114.23189.73%
10 Years2016-09-01
$ 64.07416.59%
20 Years2006-09-01
$ 12.6226x
30 Years1996-08-30
$ 2.62126x
All Time1995-04-04
$ 1.63203x

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 332.77B$ 2.62B$ 2.81B
2025$ 321.33B$ 1.55B$ 4.39B
2024$ 293.95B$ 1.50B$ 3.23B
2023$ 262.17B$ 1.74B$ 2.68B
2022$ 238.58B$ 1.69B$ 3.53B
2021$ 213.98B$ 1.53B$ 2.54B
2020$ 189.89B-$ 3.39B$ 4.59B
2019$ 179.58B$ 855M$ 3.37B
2018$ 167.93B$ 1.65B$ 2.49B
2017$ 153.14B$ 414M$ 2.43B
2016$ 146.84B$ 1.42B$ 2.76B
2015$ 135.96B-$ 134M$ 2.21B
2014$ 119.56B$ 276M$ 1.80B
2013$ 87.95B$ 433M$ 1.23B
2012$ 79.48B$ 718M$ 1.06B
2011$ 80.21B$ 706M$ 1.82B
2010$ 77.95B$ 636M$ 1.65B
2009$ 71.75B$ 503M$ 1.00B
2008$ 70.18B$ 250M$ 878M
2007$ 66.07B$ 469M$ 1.10B
2006$ 61.20B$ 467M$ 1.32B
2005$ 54.57B$ 319M$ 1.31B
2004$ 53.17B$ 468M$ 871M
2003$ 49.65B$ 441M$ 800M
2002$ 45.23B$ 344M$ 663M
2001$ 16.19B$ 125M$ 297M
2000$ 11.64B$ 99M$ 120M
1999$ 9.80B$ 67M$ 59M
1998$ 8.66B$ 50M$ 48M
1997$ 7.81B$ 45M$ 60M
1996$ 5.55B$ 35M$ 65M
IPO1995$ 4.66B$ 10M$ 32M

Where Cencora Inc. has ranked, year by year

Each point is that year's ranking on ten years of fundamentals, as a share of every company we could rank at the time. Higher is better. We show the share rather than the place because the number of companies grows — 989 in 2006, 2,060 in 2021 — so the same place means something different at either end.

Reached the top 50 on HDB Score in 3 years, the longest run being 3 in a row — but not in 2021.

2006: 1.9% · 2021: 58.3% · free through 2021 · longest runs

See where COR ranks today

You're looking at Cencora Inc.'s public company record. Membership adds the current comparative layer and continues its ranking history through recent years.

$99/year $149 founding price

Become a Member

30-day money-back guarantee.

Explore other companies